These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 18657867)
1. Peripheral blood mononuclear cell infiltration and neuroinflammation in the HexB-/- mouse model of neurodegeneration. Kyrkanides S; Miller AW; Miller JN; Tallents RH; Brouxhon SM; Olschowka ME; O'Banion MK; Olschowka JA J Neuroimmunol; 2008 Oct; 203(1):50-7. PubMed ID: 18657867 [TBL] [Abstract][Full Text] [Related]
2. Metabolic correction in microglia derived from Sandhoff disease model mice. Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Itoh K J Neurochem; 2005 Sep; 94(6):1631-8. PubMed ID: 16092933 [TBL] [Abstract][Full Text] [Related]
3. Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates. Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Kuwahara J; Yamanaka S; Itoh K J Neurochem; 2005 Mar; 92(6):1497-507. PubMed ID: 15748167 [TBL] [Abstract][Full Text] [Related]
4. Intravenous administration of scAAV9-Hexb normalizes lifespan and prevents pathology in Sandhoff disease mice. Niemir N; Rouvière L; Besse A; Vanier MT; Dmytrus J; Marais T; Astord S; Puech JP; Panasyuk G; Cooper JD; Barkats M; Caillaud C Hum Mol Genet; 2018 Mar; 27(6):954-968. PubMed ID: 29325092 [TBL] [Abstract][Full Text] [Related]
5. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice. Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605 [TBL] [Abstract][Full Text] [Related]
6. Improvement in dysmyelination by the inhibition of microglial activation in a mouse model of Sandhoff disease. Ogawa Y; Irisa M; Sano T; Yanagi Y; Furusawa E; Saito T; Yamanaka S; Itoh K; Sakuraba H; Oishi K Neuroreport; 2018 Aug; 29(11):962-967. PubMed ID: 29847465 [TBL] [Abstract][Full Text] [Related]
7. Suppression of NK and CD8 White EJ; Trigatti BL; Igdoura SA J Neuroimmunol; 2017 May; 306():55-67. PubMed ID: 28385189 [TBL] [Abstract][Full Text] [Related]
8. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease. Demir SA; Timur ZK; Ateş N; Martínez LA; Seyrantepe V J Neuroinflammation; 2020 Sep; 17(1):277. PubMed ID: 32951593 [TBL] [Abstract][Full Text] [Related]
9. Abnormal organization during neurodevelopment in a mouse model of Sandhoff disease. Ogawa Y; Sasanuma Y; Shitara S; Koshizuka A; Okada R; Sakuraba H; Oishi K Neurosci Res; 2020 Jun; 155():12-19. PubMed ID: 31340161 [TBL] [Abstract][Full Text] [Related]
10. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266 [TBL] [Abstract][Full Text] [Related]